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In tropical America, principally inNortheastern Brazil, the leaf extract ofAnacardium occidentale is traditionally used for treatment
of different diseases. However, chemical and biological properties and activities of Anacardium occidentale are poorly investigated
and known. Here, we evaluated the antioxidant and anti-inflammatory activities “in vitro” of leaf extract from Anacardium
occidentale. Our results show that leaf extract exhibits antioxidant activity when used to treat RAW 264.7 macrophage cells.
Antioxidant effects were observed by decrease in oxidative damage in macrophage cells treated with 0.5𝜇g/mL and 5𝜇g/mL of
leaf extract. Moreover, leaf extract reversed oxidative damage and inflammatory parameters induced in LPS-stimulated RAW 264.7
macrophage cells. Leaf extract at 0.5𝜇g/mL and 5𝜇g/mL was able to inhibit release of TNF-𝛼 and IL-1𝛽 in LPS-stimulated cells.
Taken together, our results indicate antioxidant and anti-inflammatory effects of leaf extract from Anacardium occidentale and
reveal the positive effects that intake of these products can mediate in biological system.
1. Introduction
Anacardium occidentale is a tropical plant that occurs prin-
cipally in Northeastern Brazil [1]. Commercially, the fruit
(cashew) of this tree is used by industries to produce juice
and derived fibers. The fruit is composed of two parts: the
fruit itself, chestnuts, and the pseudo-fruit, which is used
to produce juice [2]. Recently, the use of this fruit and its
derivatives as a nutritional food has increased. Character-
istically, cashews present different volatile compounds that
are responsible for the aroma, but can also can be involved
in allergenic clinical symptoms [3, 4]. Others biological
compounds such as flavonoids, carotenoids, and vitamins (C
and A) are also present in the fruit. These phytochemicals
compounds represent an important content which can be
related to significant biological activities. Moreover, the
cashew extract has been used as alternative medicines for
primary health care [3, 4].
Anesthetic, bactericidal, and insecticidal properties of
extracts and phytochemicals derivatives from Anacardium
occidentale have been reported by different authors [2–9].
These effects were associated with presence of anacardic acids
(AAs). AAs, which are the major compounds present in the
extract, juice, and fibers derived from cashew, are also related
to inhibition of cancer metastases, where these compounds
are able to decrease activity of matrix metalloproteinases
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(MMP) [8]. Other important effect of AAs is regulating
the activity of histone deacetylases (HDACs) [9]. These are
responsible for modulating gene expression in cells, and also
can be involved in cellular differentiation and proliferation.
Another effect recently demonstrated is the modulation of
NF-𝜅B activity in cells treatedwith extracts fromAnacardium
occidentale [7].
The anti-inflammatory properties of cashew extract, how-
ever, remain unclear. Recently, it was demonstrated that
stem bark extract alters the release and gene expression
of cytokines, as well as TNF-𝛼, IL-1, and IL-6 [7]. These
alterations were observed in neuronal and microglial cells
[7]. The potential anti-inflammatory effect from Anacardium
occidentale also was observed in different models [10–13].
Evidence that antioxidant characteristics of plant extracts are
responsible for attenuated levels of reactive oxygen species
(ROS) and reactive nitrogen species (RNS) in biological
systems was largely reported during recent years [14–16].
ROS are involved in different mechanisms that participate
in normal signalling pathways and processes such as cancer
development, neurodegenerative diseases, and cardiovascu-
lar diseases [17]. ROS also exert central involvement in
activation andprogression of inflammatory pathways [18–21].
Although metabolic process leads naturally to production of
ROS as superoxide radical anion (O2
−∙), hydrogen peroxide
(H2O2), hydroxyl radical (OH
∙), and nitric oxide (NO),
excess of these products, are involved in progression of
inflammatory response [18–21].
Here in this study, we investigated the antioxidant and
anti-inflammatory effects of leaf extract from Anacardium
occidentale in an “in vitro” model of inflammation. We
observed that leaf extracts present antioxidant activities.
Moreover, the extract was able to mediate inhibition of
proinflammatory cytokines secretion such as IL-1𝛽 and TNF-
𝛼 in lipopolysaccharides- (LPS-) stimulated macrophages
cells. These data provide evidence that leaf extract may
exert an antioxidant and anti-inflammatory role due to the
properties of biomolecules presents in the extract.
2. Materials and Methods
2.1. Chemicals and Cell Culture. Chemicals and culture rea-
gents were purchased from Sigma Chemical Co. (St. Louis,
MO, USA).Themacrophages cell line RAW 264.7 was grown
in RPMI-1640, 10% FBS, and maintained at 37∘C in an atmo-
sphere containing 5% CO2. The media were supplemented
with 1% penicillin/streptomycin.
2.2. Extract. The leaves of Anacardium occidentale were
collected in Parnamirim, Rio Grande do Norte, Brazil. The
plant material was identified by Pharmacy Faculty Center of
Federal University of Rio Grande do Norte, UFRN, Brazil.
Specimen from Anacardium occidentale was deposited at the
Herbario do Departamento de Botaˆnica, Ecologia e Zoologia
of Federal University of Rio Grande do Norte, UFRN, Brazil.
To prepare extract, the leaves of Anacardium occidentale
(plant solvent 1 : 10, w/v) were air-dried at 40∘C, powdered,
and extracted by infusionwith ethanol/water (40 : 60, v/v) for
seven days. Afterwards, the extract was filtered, lyophilized,
and stored at −80∘C until tested.
2.3. Treatments. Extract was dissolved in medium. Concen-
trated stocks were prepared immediately before experiments
by dissolved extract into medium. The solution was kept
protected from light to keep extract stable. Cells were treated
with different concentrations of extract (0.5𝜇g/mL, 5 𝜇g/mL,
and 500𝜇g/mL). All treatments were initiated by adding
concentrated solutions to reach final concentrations in the
well.
2.4. Thiobarbituric Acid-Reactive Species (TBARS), Protein
Carbonyls, and Protein Thiol Content. We measured the
formation of TBARS during an acid-heating reaction, which
is widely adopted for measurement of lipid peroxidation, as
previously described [22]. Results are expressed as nmol of
TBARS/mg of protein [23]. Protein carbonyls were deter-
mined based on the reaction with dinitrophenylhydrazine,
as previously described [24]. Results are expressed as nmol
of carbonyl/mg of protein. For protein thiol content the
samples were evaluated to estimate oxidative alterations in
protein thiol content, as previously described [25]. Results are
expressed as mmol of SH/mg of protein.
2.5. Estimation of Antioxidant Enzyme Activities. Catalase
(EC 1.11.1.6) (CAT) activity was determined through measur-
ing the rate of decrease in H2O2 absorbance in a spectropho-
tometer at 240 nm, and the results are expressed as units of
CAT/mg of protein [26]. Superoxide dismutase (EC 1.15.1.1)
(SOD) activity was assessed by quantifying the inhibition of
superoxide-dependent adrenaline autooxidation in a spec-
trophotometer at 480 nm, as previously described, and the
results are expressed a units of SOD/mg of protein [18].
2.6. Determination of Intracellular RS Production (Real-Time
Dichlorofluorescein Oxidation Assay). Intracellular reactive
species production was determined by the DCFH-DA-based
real-time assay using intact RAW 264.7 cells [19].
2.7. MTT Assay and Sulphorhodamine B (SRB) Assay. After
24 h of leaf extract treatments, RAW 264.7 cells viability
was assessed by the MTT assay [20]. This colorimetric assay
was performed to assess growth of the cells. It estimates cell
numbers indirectly by staining total cellular protein with SRB
[21].
2.8. Indirect ELISA. TNF-𝛼was quantified by indirect ELISA.
IL-1𝛽 was detected by Abcam IL-1 beta Mouse ELISA
(Enzyme-Linked Immunosorbent Assay) (Catalog number:
ab100704) Immunoassay Kit following the manufacturer
instructions.
2.9. Statistical Analysis. Results are expressed as mean values
± standard error of themean (SEM);𝑝 valueswere considered
significant when 𝑝 < 0.05. Differences in experimental
groups were determined by one-way ANOVA followed by the
post hoc Tukey’s test whenever necessary.
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Figure 1: Parameters of cell viability and oxidative stress in RAW 264.7 cells treated with Anacardium occidentale leaf extract for 24 hours.
RAW 264.7 cells were treated with leaf extract at different concentrations, 0.5, 5, and 500𝜇g/mL. Different assays were performed to evaluate
cell viability after incubation; lipopolysaccharides LPS (1 𝜇g/mL) was used as a positive control for loss of viability. (a) MTT assay and (b)
SRB–incorporation assay. Control group is represented in all graphs by “Control.” Data represent mean ± SEM from three independent
experiments (𝑛 = 6 per group). One-way ANOVA followed by the post hoc Tukey’s test, ∗𝑝 < 0.05 versus the control group.
3. Results
RAW 264.7 macrophage cells were treated with Anacardium
occidentale extract at concentrations of 0.5𝜇g/mL, 5𝜇g/mL,
and 500 𝜇g/mL (Figure 1) for determination of viabil-
ity. Treatment with 500 𝜇g/mL of leaf extract significantly
decreased cell viability during the first 24 hours. In counter-
point, this was not visualized at the two lowest concentrations
as indicated throughMTT and SRB assays. At the same time,
we analyzed the effects of cotreatment during the inflam-
matory response mediated by treatment with LPS at 1 𝜇g/mL.
At concentrations of 0.5 𝜇g/mL and 5𝜇g/mL, cotreatment
with the extract inhibited the decrease in LPS-mediated cell
viability (Figure 1).
The levels of lipid peroxidation and carbonylation of pro-
teins decreased at concentrations of 0.5 𝜇g/mL and 5 𝜇g/mL
(Table 1) when compared to the control group in cells treated
with leaf extract for 24 hours. Additionally, the cotreatment
of cells with the extract blocked the LPS-mediated effect
on macrophage cells in both lipid peroxidation and pro-
tein carbonylation (Table 1). In contrast, the protein thiol
content was not altered by the treatments with the extract
(Table 1). Interestingly, cotreatment with doses of 0.5𝜇g/mL
and 5𝜇g/mL inhibited the effect mediated by LPS on the
protein thiol content in macrophages cells (Table 1).
The activity of the antioxidant enzymes was modified
during treatment with Anacardium occidentale leaf extract.
However, these effects were only observed on LPS-stimulated
cells. The activities of CAT and SOD in cells treated with
leaf extract without LPS stimulation did not show significant
changes (Table 1). However, it was found that leaf extract pre-
vented the LPS-stimulated effects on CAT and SOD activities
(Table 1).These effects were observed in cells treated with leaf
extract at 5 𝜇g/mL.Thus, these data provide evidence that the
leaf extract of Anacardium occidentale exhibits antioxidant
properties that resulted in the inhibition of redox damage
induced by LPS.
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Figure 2: Cells were treated with different concentrations of leaf
extract for 1 hour and the total production of reactive species by
living cells was evaluated by the real-time DCFH oxidation assay;
LPS (1 𝜇g/mL) was used as a positive control for reactive species
production and fluorescence intensity was calculated relative to
control cells. Control group is represented in all graphs by “Control.”
Data represent mean ± SEM from three independent experiments
(𝑛 = 6 per group). One-way ANOVA followed by the post hoc
Tukey’s test, ∗𝑝 < 0.05 versus the control group; ∗∗𝑝 < 0.05 versus
treated group.
The real-time DCFH oxidation assay was used to eval-
uate the ROS/RNS production in macrophages cells treated
with the Anacardium occidentale leaf extract. It observed
inhibition in cellular ROS/RNS production at concentra-
tions of 0.5 𝜇g/mL and 5𝜇g/mL (Figure 2). Reaffirming
the antioxidant properties of leaf extract, the production
of intracellular reactive species in the cotreatment of LPS-
stimulated macrophages was assessed by DCF fluorescence
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Figure 3: The levels of IL-1𝛽 (a) and TNF-𝛼 (b) in medium of incubation were measured. Detection of cytokines was performed by ELISA
assays. Control group is represented in all graphs by “Control.” Data represent mean ± SEM from three independent experiments (𝑛 = 6 per
group). One-way ANOVA followed by the post hoc Tukey’s test, ∗𝑝 < 0.05 versus the control group; ∗∗𝑝 < 0.05 versus treated group.
(Figure 2). Our results showed that the treatment with leaf
extract was able to decrease the detection of ROS/RNS in
DCFH assays.
Secretion of inflammatory cytokines such as TNF-𝛼 and
IL-1𝛽 is induced when macrophage cells are LPS-stimulated.
Here, we showed that the cotreatment with the extract of the
leaves of Anacardium occidentalemediated a reduction in the
secretion of TNF-𝛼 and IL-1𝛽 (Figure 3) at different concen-
trations. Taken together, these data suggest that Anacardium
occidentale leaf extract has anti-inflammatory properties.
4. Discussion
The diversity of secondary metabolites produced for the
plants has been extensively studied in last years, princi-
pally due to the redox, anti-inflammatory, and antitumoral
properties [27–30]. In this terms, Anacardium occidentale is
one of the species that in Northeastern Brazil have higher
importance to public health [1]. Usually, the extract of
this plant is used therapeutically with medicinal objectives
for treatment of different diseases, including inflammation,
diabetes, arteriosclerosis, respiratory diseases, and neurode-
generative disorders [1]. However, the effects presented by
extracts from different tissues of the Anacardium occidentale
remain to be elucidated. Here, our data reveal evidence that
Anacardium occidentale leaf extract can exhibit antioxidant
and anti-inflammatory activities in a biological system.
First, we investigate the viability of cells treated with
Anacardiumoccidentale leaf extract.TheMTTand SRB assays
were carried out to evaluate the viability/toxicity of extract in
RAW 264.7 macrophage cells. The higher dose of 500𝜇g/mL
of extract treatment induced significantly the decrease in cell
viability. In the lowest concentration the Anacardium occi-
dentale leaf extract did not show alterations in cell viability.
When the cells were LPS-stimulated, the lowest doses of
0.5 𝜇g/mL and 5𝜇g/mL cotreatment inhibited the decrease in
cell viabilitymediated by LPS. It is known that phytochemical
composition of the plant Anacardium occidentale presents
phenolic compounds, such as quercetin, anthocyanins, and
tannins [31–33].These phytochemical compounds are related
to several biological activities, including antioxidants, apop-
totic, antiapoptotic, and anti-inflammatory activities [34].
Previous studies have demonstrated that treatment with LPS
in macrophages cells leads to impairment of the electron
transfer system, thus increasing the rate of O2
−∙ production,
and, respectively, the damage in lipids, proteins, and DNA
[35]. The consequence of this damage is a decrease in cell
viability. Our results showed that leaf extract cotreatment
inhibited the decrease in cell viability of LPS-stimulated cells.
We suggest that the effect observed in cell viability can be
associated with different compounds present in Anacardium
occidentale leaf extracts, which are associated with antioxi-
dant properties.
It is known that production of ROS/RNS is a process that
occurs naturally during cellular metabolism; however higher
levels of ROS/RNS production have been associated with
impairment of metabolic functions [36]. Plants and deriva-
tives present a diversity of antioxidant and anti-inflammatory
properties. Based on these characteristics, there is a stimu-
lation to the intake of these products, principally due to it
helping in maintaining the functions in biological systems
[30]. Additionally, several studies have demonstrated the
involvement of ROS/RNS with increased risk and incidence
of chronic diseases such as arteriosclerosis, respiratory dis-
eases, diabetes, and neurodegenerative disorders [37]. These
findings reinforce the use of plant extracts through tea, juice,
or food supplementation as a mechanism to improve the
treatment and/or prevention of those different pathological
conditions [38, 39]. Here, our results showed for the first time
thatAnacardiumoccidentale leaf extract treatment at different
doses exhibits antioxidant and anti-inflammatory effects in
macrophage cells.
The extract inhibited the effectsmediated by LPS on redox
parameters when used as cotreatment in macrophage cells
that were LPS-stimulated. Leaf extract decreased lipid per-
oxidation, protein carbonylation, and protein thiol content.
The activities of CAT and SOD were also modulated by leaf
extract of Anacardium occidentale. A class of compounds
present in Anacardium occidentale that have been associated
with antioxidant, anti-inflammatory, and antitumoral effects
are AAs [8, 33, 40–45].These compounds likely contribute to
reduce ROS/RNS. Furthermore, AAs are effective in inducing
inhibition of prooxidant enzymes responsible for ROS/RNS
production. AAs also present chemical properties of chelate
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divalent metal ions and therefore can reduce reactions that
trigger ROS/RNS production, such as Fenton reaction [40,
46, 47]. In LPS-stimulated cells the formation of both O2
−∙
and hydroxyl radical (OH∙) is related to oxidative damage
observed in cells. Our results in ROS/RNS production,
evaluated through DCF assay, provide evidence that LPS
induces these alterations. Interestingly, the cotreatment with
leaf extract prevents these alterations. Taken together, our
data suggest thatAnacardium occidentale leaf extract presents
antioxidant properties that induce the cellular response to
injury, principally in redox parameters.
During proinflammatory response in LPS-stimulated
cells the release of cytokines such as IL-1𝛽 and TNF-
𝛼 occurs characteristically. IL-1𝛽 action is well character-
ized in terms of IL-1 cytokine family [48]. The blocked
IL-1𝛽 action/secretion have been associated with anti-
inflammatory responses [48]. Our results demonstrated that
cotreatment with leaf extract at different doses was able to
mediate the inhibition of IL-1𝛽 secretion in macrophages
that were LPS-stimulated. The importance of inhibition of
IL-1𝛽 secretion/activation has been associated with decrease
in inflammasome activation, and therefore the physiological
response mediated principally for macrophage cells [18–20].
TNF-𝛼 secretion also corroborates the immunological system
for inducing inflammation in pathological conditions [49]. In
target cells TNF-𝛼 is involved in ROS/RNS production [50].
It is yet unclear the mechanisms involved TNF-𝛼 pathway
signalling for inducing ROS/RNS production; however it has
been demonstrated that this cytokine alters mitochondrial
function and as a consequence increases ROS production
[51]. Here, we showed that Anacardium occidentale leaf
extract treatment blocked secretion of cytokines such as IL-
1𝛽 and TNF-𝛼 in macrophage LPS-stimulated cells. These
findings demonstrate that this extract can present anti-
inflammatory properties. Our data suggest that both anti-
inflammatory and antioxidant effects observed in our study
are derivatives from synergistic effect of biological com-
pounds present in leaf extract of Anacardium occidentale.
In conclusion, the results presented here demonstrate for
the first time that the leaf extract of Anacardium occidentale
exhibits antioxidant and anti-inflammatory properties in a
biological system. Moreover, our data provide evidence that
reinforces the importance of potential health benefits that
the consumption of Anacardium occidentale derivatives may
promote. Our findings also contribute to improving the
comprehension of the properties and mechanism of action
mediated by Anacardium occidentale biological compounds.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Acknowledgments
This work was funded by National Counsel of Technological
and Scientific Development (CNPq) (Grants 400805/2014-6,
444856/2014-5, 443514/2014-3, and 467393/2014-1).
References
[1] V. De Carvalho Nilo Bitu, V. De Carvalho Nilo Bitu, E. F. F.
Matias et al., “Ethnopharmacological study of plants sold for
therapeutic purposes in public markets in Northeast Brazil,”
Journal of Ethnopharmacology, vol. 172, article 9584, pp. 265–
272, 2015.
[2] R. A. da Silva, R. R. Dihl, D. N. e Santos et al., “Evaluation
of antioxidant and mutagenic activities of honey-sweetened
cashew apple nectar,” Food and Chemical Toxicology, vol. 62, pp.
61–67, 2013.
[3] I. Kubo, T.Nitoda, F. E. Tocoli, and I. R. Green, “Multifunctional
cytotoxic agents from Anacardium occidentale,” Phytotherapy
Research, vol. 25, no. 1, pp. 38–45, 2011.
[4] M. Kulis, I. MacQueen, Y. Li, R. Guo, X.-P. Zhong, and A.
W. Burks, “Pepsinized cashew proteins are hypoallergenic and
immunogenic and provide effective immunotherapy in mice
with cashew allergy,” Journal of Allergy and Clinical Immunol-
ogy, vol. 130, no. 3, pp. 716–723, 2012.
[5] I. Castillo-Jua´rez, F. Rivero-Cruz, H. Celis, and I. Romero,
“Anti-Helicobacter pylori activity of anacardic acids from Am-
phipterygium adstringens,” Journal of Ethnopharmacology, vol.
114, no. 1, pp. 72–77, 2007.
[6] O. A. Olajide, M. A. Aderogba, A. D. A. Adedapo, and J. M.
Makinde, “Effects of Anacardium occidentale stem bark extract
on in vivo inflammatory models,” Journal of Ethnopharmacol-
ogy, vol. 95, no. 2-3, pp. 139–142, 2004.
[7] O. A. Olajide, M. A. Aderogba, and B. L. Fiebich, “Mechanisms
of anti-inflammatory property of Anacardium occidentale
stem bark: Inhibition of NF-𝜅B and MAPK signalling in the
microglia,” Journal of Ethnopharmacology, vol. 145, no. 1, pp. 42–
49, 2013.
[8] A.Omanakuttan, J. Nambiar, R.M.Harris et al., “Anacardic acid
inhibits the catalytic activity of matrix metalloproteinase-2 and
matrix metalloproteinase-9,” Molecular Pharmacology, vol. 82,
no. 4, pp. 614–622, 2012.
[9] Y. Sun, X. Jiang, S. Chen, and B. D. Price, “Inhibition of histone
acetyltransferase activity by anacardic acid sensitizes tumor
cells to ionizing radiation,” FEBS Letters, vol. 580, no. 18, pp.
4353–4356, 2006.
[10] N. S. Carvalho, M. M. Silva, R. O. Silva et al., “Gastroprotective
properties of cashew gum, a complex heteropolysaccharide of
Anacardium occidentale, in naproxen-induced gastrointestinal
damage in rats,” Drug Development Research, vol. 76, no. 3, pp.
143–151, 2015.
[11] M. da Silveira Vasconcelos, N. F. Gomes-Rochette, M. L. M. de
Oliveira et al., “Anti-inflammatory andwound healing potential
of cashew apple juice (Anacardium occidentale L.) in mice,”
Experimental Biology and Medicine, vol. 240, no. 12, pp. 1648–
1655, 2015.
[12] H. B. H. Khan, K. S. Vinayagam, B. T. Moorthy, S. Palanivelu,
and S. Panchanatham, “Anti-inflammatory and anti-hyperlip-
idemic effect of semecarpus anacardium in a high fat diet: STZ-
induced type 2 diabetic rat model,” Inflammopharmacology, vol.
21, no. 1, pp. 37–46, 2013.
[13] M. S. De Arau´jo Vilar, G. L. De Souza, D. De Arau´jo Vilar et
al., “Assessment of phenolic compounds and anti-inflammatory
activity of ethyl acetate phase of Anacardium occidentale L.
bark,”Molecules, vol. 21, no. 8, article 1087, 2016.
[14] B. Armenda´riz-Barraga´n, N. Zafar, W. Badri et al., “Plant
extracts: from encapsulation to application,” Expert Opinion on
Drug Delivery, vol. 13, no. 8, pp. 1165–1175, 2016.
Evidence-Based Complementary and Alternative Medicine 7
[15] Z. Kalaycıog˘lu and F. B. Erim, “Total phenolic contents,
antioxidant activities, and bioactive ingredients of juices from
pomegranate cultivars worldwide,” Food Chemistry, vol. 221, pp.
496–507, 2017.
[16] G. N.Mattos, R. V. Tonon, A. A. L. Furtado, and L.M. C. Cabral,
“Grape by-product extracts against microbial proliferation and
lipid oxidation: a review,” Journal of the Science of Food and
Agriculture, vol. 97, no. 4, pp. 1055–1064, 2017.
[17] S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal,
“Oxidative stress, inflammation, and cancer: how are they
linked?” Free Radical Biology and Medicine, vol. 49, no. 11, pp.
1603–1616, 2010.
[18] C. Conforti-Andreoni, P. Ricciardi-Castagnoli, and A. Mortel-
laro, “The inflammasomes in health and disease: From genetics
to molecular mechanisms of autoinflammation and beyond,”
Cellular and Molecular Immunology, vol. 8, no. 2, pp. 135–145,
2011.
[19] M. Lamkanfi and V. M. Dixit, “Inflammasomes and their roles
in health and disease,”Annual Review of Cell andDevelopmental
Biology, vol. 28, pp. 137–161, 2012.
[20] T. Strowig, J. Henao-Mejia, E. Elinav, and R. Flavell, “Inflam-
masomes in health and disease,” Nature, vol. 481, no. 7381, pp.
278–286, 2012.
[21] M. C. Tal, M. Sasai, H. K. Lee, B. Yordy, G. S. Shadel, and
A. Iwasaki, “Absence of autophagy results in reactive oxygen
species-dependent amplification of RLR signaling,” Proceedings
of the National Academy of Sciences, vol. 106, no. 8, pp. 2770–
2775, 2009.
[22] H.H.Draper, E. J. Squires,H.Mahmoodi, J.Wu, S. Agarwal, and
M. Hadley, “A comparative evaluation of thiobarbituric acid
methods for the determination of malondialdehyde in biologi-
cal materials,” Free Radical Biology and Medicine, vol. 15, no. 4,
pp. 353–363, 1993.
[23] O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall,
“Protein measurement with the Folin phenol reagent,” Journal
of Biologycal Chemistry, vol. 193, pp. 265-75, 1951.
[24] R. L. Levine, D. Garland, C. N. Oliver et al., “Determination of
carbonyl content in oxidatively modified proteins,” Methods in
Enzymology, vol. 186, pp. 464–478, 1990.
[25] G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochem-
istry and Biophysics, vol. 82, no. 1, pp. 70–77, 1959.
[26] H. Aebi, “Catalase in vitro,”Methods in Enzymology, vol. 105, pp.
121–126, 1984.
[27] G. R.Gandhi, P.G. Barreto, B.D. S. Lima et al., “Medicinal plants
and natural molecules with in vitro and in vivo activity against
rotavirus: A systematic review,” Phytomedicine, vol. 23, no. 14,
pp. 1830–1842, 2016.
[28] E. Martinez-Klimova, K. Rodr´ıguez-Pen˜a, and S. Sa´nchez,
“Endophytes as sources of antibiotics,” Biochemical Pharmacol-
ogy, 2016.
[29] I. V. Ogungbe and W. N. Setzer, “The Potential of secondary
metabolites from plants as drugs or leads against protozoan
neglected diseases-Part III: In-Silico molecular docking inves-
tigations,”Molecules, vol. 21, no. 10, article 1389, 2016.
[30] F. M. F. Roleira, E. J. Tavares-da-Silva, C. L. Varela et al., “Plant
derived and dietary phenolic antioxidants: anticancer proper-
ties,” Food Chemistry, vol. 183, pp. 235–258, 2015.
[31] V. Viswanath, V. V. Leo, S. Sabna Prabha, C. Prabhakumari, V.
P. Potty, andM. S. Jisha, “Thermal properties of tannin extracted
from Anacardium occidentale L. using TGA and FT-IR spec-
troscopy,” Natural Product Research, vol. 30, no. 2, pp. 223–227,
2016.
[32] F. P. De Abreu, M. Dornier, A. P. Dionisio, M. Carail, C. Caris-
Veyrat, and C. Dhuique-Mayer, “Cashew apple (Anacardium
occidentale L.) extract from by-product of juice processing: A
focus on carotenoids,” Food Chemistry, vol. 138, no. 1, pp. 25–31,
2013.
[33] J. Trox, V. Vadivel, W. Vetter et al., “Bioactive compounds
in cashew nut (anacardium occidentale l.) kernels: Effect of
different shelling methods,” Journal of Agricultural and Food
Chemistry, vol. 58, no. 9, pp. 5341–5346, 2010.
[34] S. Gorlach, J. Fichna, and U. Lewandowska, “Polyphenols as
mitochondria-targeted anticancer drugs,” Cancer Letters, vol.
366, no. 2, pp. 141–149, 2015.
[35] E. L. Mills, B. Kelly, A. Logan et al., “Succinate Dehydrogenase
Supports Metabolic Repurposing of Mitochondria to Drive
Inflammatory Macrophages,” Cell, vol. 167, no. 2, pp. 457–
470.e13, 2016.
[36] A. Sanz and R. K. A. Stefanatos, “Themitochondrial free radical
theory of aging: a critical view,”Current Aging Science, vol. 1, no.
1, pp. 10–21, 2008.
[37] X. Wen, J. Wu, F. Wang, B. Liu, C. Huang, and Y. Wei, “Decon-
voluting the role of reactive oxygen species and autophagy in
human diseases,” Free Radical Biology and Medicine, vol. 65, pp.
402–410, 2013.
[38] L. Davis, W. Stonehouse, D. T. Loots et al., “The effects of high
walnut and cashewnut diets on the antioxidant status of subjects
with metabolic syndrome,” European Journal of Nutrition, vol.
46, no. 3, pp. 155–164, 2007.
[39] R. Rico, M. Bullo´, and J. Salas-Salvado´, “ Nutritional composi-
tion of raw fresh cashew ( ,” Food Science & Nutrition, vol. 4, no.
2, pp. 329–338, 2016.
[40] I. Kubo, J. H. Tae, K. Tsujimoto, F. E. Tocoli, and I. R. Green,
“Evaluation of lipoxygenase inhibitory activity of anacardic
acids,” Zeitschrift fur Naturforschung - Section C Journal of
Biosciences, vol. 63, no. 7-8, pp. 539–546, 2008.
[41] C. Ge´ny, G. Rivie`re, J. Bignon et al., “Anacardic Acids from
Knema hookeriana as Modulators of Bcl-xL/Bak andMcl-1/Bid
Interactions,” Journal of Natural Products, vol. 79, no. 4, pp. 838–
844, 2016.
[42] T. J. Ha and I. Kubo, “Lipoxygenase inhibitory activity of
anacardic acids,” Journal of Agricultural and Food Chemistry,
vol. 53, no. 11, pp. 4350–4354, 2005.
[43] F. B.Hamad andE. B.Mubofu, “Potential biological applications
of bio-based anacardic acids and their derivatives,” International
Journal ofMolecular Sciences, vol. 16, no. 4, pp. 8569–8590, 2015.
[44] S. J. Lee, W.-H. Park, and H.-I. Moon, “Bioassay-guided iso-
lation of antiplasmodial anacardic acids derivatives from the
whole plants of Viola websteri Hemsl,” Parasitology Research,
vol. 104, no. 2, pp. 463–466, 2009.
[45] D. Wang, T. J. Girard, T. P. Kasten, R. M. LaChance, M.
A. Miller-Wideman, and R. C. Durley, “Inhibitory activity of
unsaturated fatty acids and anacardic acids toward soluble tissue
factor-factor VIIa complex,” Journal of Natural Products, vol. 61,
no. 11, pp. 1352–1355, 1998.
[46] N. Masuoka and I. Kubo, “Characterization of xanthine oxi-
dase inhibition by anacardic acids,” Biochimica et Biophysica
Acta—Molecular Basis of Disease, vol. 1688, no. 3, pp. 245–249,
2004.
[47] K. Tsujimoto, A. Hayashi, J. H. Tae, and I. Kubo, “Anacardic
acids and ferric ion chelation,” Zeitschrift fur Naturforschung -
Section C Journal of Biosciences, vol. 62, no. 9-10, pp. 710–716,
2007.
8 Evidence-Based Complementary and Alternative Medicine
[48] G. Schett, J.-M. Dayer, and B. Manger, “Interleukin-1 function
and role in rheumatic disease,” Nature Reviews Rheumatology,
vol. 12, no. 1, pp. 14–24, 2016.
[49] T. A. Wynn, A. Chawla, and J. W. Pollard, “Macrophage biology
in development, homeostasis and disease,” Nature, vol. 496, no.
7446, pp. 445–455, 2013.
[50] P. Gan, Z. Gao, X. Zhao, and G. Qi, “Surfactin inducing
mitochondria-dependent ROS to activate MAPKs, NF-𝜅 B and
inflammasomes inmacrophages for adjuvant activity,” Scientific
Reports, vol. 6, Article ID 39303, 2016.
[51] I. I. Galkin, O. Y. Pletjushkina, R. A. Zinovkin, V. V. Zakharova,
B. V. Chernyak, and E. N. Popova, “Mitochondria-targeted anti-
oxidant SkQR1 reduces TNF-induced endothelial permeability
in vitro,” Biochemistry (Moscow), vol. 81, no. 10, pp. 1188–1197,
2016.
Submit your manuscripts at
https://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
